In parallel, in vitro studies have suggested that ghrelin and D-Lys3-GHRP-6, an inhibitor of the ghrelin receptor to the ovarian cancer cells line HO-8910, induced the apoptosis of HO-8910 cells through phosphorylated ERK1/2 [48]. Here, MAPK3 is linked to ovarian carcinoma.